VANGUARD GROUP INC - TREVI THERAPEUTICS INC ownership

TREVI THERAPEUTICS INC's ticker is TRVI and the CUSIP is 89532M101. A total of 54 filers reported holding TREVI THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of TREVI THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$4,268,167
-6.7%
1,957,875
+2.3%
0.00%
Q2 2023$4,572,696
+64.8%
1,913,262
+27.6%
0.00%
Q1 2023$2,774,540
-0.1%
1,499,751
+4.2%
0.00%
Q4 2022$2,778,414
+36.2%
1,439,593
+8.7%
0.00%
Q3 2022$2,040,000
+206.3%
1,324,377
+459.0%
0.00%
Q2 2022$666,000
+98.2%
236,940
+55.0%
0.00%
Q1 2022$336,000
+202.7%
152,831
+7.6%
0.00%
Q4 2021$111,000
-42.2%
142,051
+4.0%
0.00%
Q3 2021$192,000
-36.0%
136,549
+2.5%
0.00%
Q2 2021$300,000
-16.9%
133,2150.0%0.00%
Q1 2021$361,000
+12.1%
133,2150.0%0.00%
Q4 2020$322,000
-40.0%
133,2150.0%0.00%
Q3 2020$537,000
-41.2%
133,215
-4.1%
0.00%
Q2 2020$914,000
+84.6%
138,915
-7.7%
0.00%
Q1 2020$495,000
-12.2%
150,4320.0%0.00%
Q4 2019$564,000
-16.7%
150,4320.0%0.00%
Q3 2019$677,000
-23.6%
150,432
+27.4%
0.00%
Q2 2019$886,000118,0910.00%
Other shareholders
TREVI THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Omega Fund Management, LLC 1,263,408$2,843,0000.32%
NEA Management Company, LLC 5,940,796$13,367,0000.17%
TPG Group Holdings (SBS) Advisors, Inc. 4,824,883$10,856,0000.08%
WealthTrust Axiom LLC 39,500$88,0000.03%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 34,600$78,0000.00%
BlackRock Inc. 44,180$99,0000.00%
LPL Financial LLC 10,000$23,0000.00%
Alberta Investment Management Corp 25,000$56,0000.00%
Tower Research Capital LLC (TRC) 4,187$10,0000.00%
Renaissance Technologies 92,600$208,0000.00%
View complete list of TREVI THERAPEUTICS INC shareholders